Bvf Inc Mirum Pharmaceuticals, Inc. Transaction History
Bvf Inc
- $3.27 Billion
- Q2 2024
A detailed history of Bvf Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Bvf Inc holds 4,370,024 shares of MIRM stock, worth $177 Million. This represents 4.57% of its overall portfolio holdings.
Number of Shares
4,370,024
Previous 4,370,024
-0.0%
Holding current value
$177 Million
Previous $110 Million
36.11%
% of portfolio
4.57%
Previous 3.29%
Shares
3 transactions
Others Institutions Holding MIRM
# of Institutions
172Shares Held
54.2MCall Options Held
96.1KPut Options Held
54.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$262 Million13.09% of portfolio
-
Janus Henderson Group PLC London, X04.99MShares$202 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.61MShares$146 Million2.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$131 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.45MShares$98.8 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.48B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...